Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by tylerreddickon Apr 08, 2024 10:59am
98 Views
Post# 35976719

RE:RE:New Press Release - SIRONA BIOCHEM Corporate Update April 2024

RE:RE:New Press Release - SIRONA BIOCHEM Corporate Update April 2024
Turtle4 wrote: Nothing new.
family and friends can't or don't want to give any more money.
The available resources are not even sufficient to produce enough samples for potential partners.

The only thing that is important at the moment is the investor. Without it, everything is for nothing. Even the TFC1067 launch will not be nearly enough. Milestones are probably very low (clever howie opted for higher royalties) and royalties will certainly take a few quarters.


Howie didn't "opt" for anything, he took what AbbVie offered, like any beggar on the street. And now, the shareholders are paying the price.

I don't know what kind of "institution" is going to fund us until we can make some money, but they are going to want a sweetheart deal, and that is going to take a big chunk of the future profits that WE paid for.

Having said that, even if we get a smaller piece of the pie, it is better than a larger piece of a bankrupt company. If this rebranded GlycoProteMim takes off, and AbbVie ever decides to do something, that smaller peice of the pie will still make anyone who buys at 7 cents a heck of a lot of money.
<< Previous
Bullboard Posts
Next >>